Announcements Trials

Browse Landscape

Phase

Phase 2 2 Phase 1/2 2 Phase 1 2 Phase 4 1 Phase 3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 79 Triple Negative Breast Neoplasms 9 Stomach Neoplasms 8 Inflammatory Breast Neoplasms 6 Carcinoma, Hepatocellular 6 Non-Muscle Invasive Bladder Neoplasms 3 Esophageal Neoplasms 3 Sarcoma 2 Primary Breast Cancer 2 Pathologic Complete Response 2 Lung Neoplasms 2 Carcinoma, Ductal, Breast 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Rhabdomyosarcoma 1 Resectable HER2-positive Breast Cancer 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Complications 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Oesophago-gastric Cancer 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms, Unknown Primary 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Malignant mesenchymal tumor 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1

Interventions

Paclitaxel 20 Gemcitabine 16 Dexamethasone 16 Bevacizumab 16 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Fluorouracil 11 Leucovorin 10 Cisplatin 10 pembrolizumab 9 Prednisone 9 Pemetrexed 9 Epoetin Alfa 9 venetoclax 8 atezolizumab 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Epirubicin × Clear all

NCT00798070 2024-12-18

PANTHER

Karolinska University Hospital

Phase 3 Active not recruiting

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡